Table 2.
Pre-challenge MPO concentrations in the subjects who did versus who did not seroconvert following challenge
| Antigen |
Not seroconverted GM (Range) |
Seroconverted GM (Range) |
p value |
|---|---|---|---|
| Serum IgA | |||
| CFA/I | 438.9(88.1–1566.6) | 84.4(25–243.9) | 0.0014 |
| LTB | 107.2(25–1566.6) | 325.4(88.1–1086.4) | 0.0434 |
| Serum IgG | |||
| CFA/I | 204(25–1566.6) | 83(30.6–243.9) | 0.3422 |
| LTB | 158.9(25–1566.6) | 205.4(31.3–1086.4) | 0.9544 |
| ALS IgA | |||
| CFA/I | 256.6(30.6–1566.6) | 109.3(25–299.5) | 0.0831 |
| LTB | 179.2(30.6–1566.6) | 172.7(25–566.2) | 1 |
GM: Geometric mean